Skip to content
Governance Register

← US public companies

Coherus Oncology, Inc.

SEC CIK 1512762 · CHRS · last insider filing 2026-06-09

Directors (from insider filings)

NameCapacity as filedFilings
Wahlstrom Mats Director filed 2014 - 2026
Karachun Rita A Director filed 2024 - 2026
Satvat Ali J. Director filed 2014 - 2026
Newcomer Lee Nisley Director filed 2022 - 2026
Newton Charles W. Director filed 2022 - 2026
O'Donnell-Tormey Jill Director filed 2022 - 2026
Ryan Michael Lee Director filed 2023 - 2026
Lanfear Dennis M Director · See Remarks filed 2014 - 2026
Erbez Georgia Director filed 2024 - 2025
Stolper Mark Director filed 2021 - 2024
Tzoumakas Kimberly JO Director filed 2020 - 2024
Healy James Director filed 2014 - 2022
Mendelson Alan C Director filed 2021 - 2021
Nussbaum Samuel R MD Director filed 2018 - 2021
Lawlis V Bryan Director filed 2014 - 2021
Szela Mary T Director filed 2014 - 2021
Richards Christos Director filed 2014 - 2020
Troendle August J. Director filed 2014 - 2018

Officers (from insider filings)

NameTitle as filedFilings
Mcmichael Bryan J See Remarks filed 2022 - 2026
Reider Paul Chief Commercial Officer filed 2023 - 2025
Stilwell Mcdavid Chief Financial Officer filed 2021 - 2024
Vexler Vladimir Chief Scientific Officer filed 2018 - 2023
Anicetti Vincent R Chief, Quality & Compliance filed 2018 - 2021
Viret Jean-Frederic Chief Financial Officer filed 2014 - 2021
Horton Darlene P See Remarks filed 2019 - 2019
Finck Barbara K Chief Medical Officer filed 2014 - 2018
Watler Peter K. Chief Technical Officer filed 2014 - 2018
Herman Alan C. Chief Scientific Officer filed 2014 - 2017

About this record

From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.

Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.